WO2002046385A3 - Enzymes - Google Patents

Enzymes Download PDF

Info

Publication number
WO2002046385A3
WO2002046385A3 PCT/US2001/047432 US0147432W WO0246385A3 WO 2002046385 A3 WO2002046385 A3 WO 2002046385A3 US 0147432 W US0147432 W US 0147432W WO 0246385 A3 WO0246385 A3 WO 0246385A3
Authority
WO
WIPO (PCT)
Prior art keywords
nzms
provides
enzymes
polynucleotides
agonists
Prior art date
Application number
PCT/US2001/047432
Other languages
English (en)
Other versions
WO2002046385A2 (fr
Inventor
Y Tom Tang
Jennifer A Griffin
Henry Yue
Ernestine A Lee
Mariah R Baughn
Brendan M Duggan
Narinder K Walia
Sally Lee
Jayalaxmi Ramkumar
Bridget A Warren
Ameena R Gandhi
Dyung Aina M Lu
Yan Lu
Monique G Yao
Li Ding
Catherine M Tribouley
Madhu M Sanjanwala
Chandra Arvizu
Jennifer L Jackson
Original Assignee
Incyte Genomics Inc
Y Tom Tang
Jennifer A Griffin
Henry Yue
Ernestine A Lee
Mariah R Baughn
Brendan M Duggan
Narinder K Walia
Sally Lee
Jayalaxmi Ramkumar
Bridget A Warren
Ameena R Gandhi
Dyung Aina M Lu
Yan Lu
Monique G Yao
Li Ding
Catherine M Tribouley
Madhu M Sanjanwala
Chandra Arvizu
Jennifer L Jackson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Y Tom Tang, Jennifer A Griffin, Henry Yue, Ernestine A Lee, Mariah R Baughn, Brendan M Duggan, Narinder K Walia, Sally Lee, Jayalaxmi Ramkumar, Bridget A Warren, Ameena R Gandhi, Dyung Aina M Lu, Yan Lu, Monique G Yao, Li Ding, Catherine M Tribouley, Madhu M Sanjanwala, Chandra Arvizu, Jennifer L Jackson filed Critical Incyte Genomics Inc
Priority to JP2002548103A priority Critical patent/JP2004530415A/ja
Priority to AU2002236595A priority patent/AU2002236595A1/en
Priority to CA002428390A priority patent/CA2428390A1/fr
Priority to US10/433,802 priority patent/US20040063115A1/en
Priority to EP01986129A priority patent/EP1339834A2/fr
Publication of WO2002046385A2 publication Critical patent/WO2002046385A2/fr
Publication of WO2002046385A3 publication Critical patent/WO2002046385A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Microbiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des enzymes humaines (NZMS) et des polynucléotides qui identifient et codent pour des enzymes NZMS. Elle concerne aussi des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Elle concerne enfin des procédés de diagnostic, de traitement, ou de prévention de troubles associés à l'expression aberrante d'enzymes NZMS.
PCT/US2001/047432 2000-12-07 2001-12-04 Enzymes WO2002046385A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2002548103A JP2004530415A (ja) 2000-12-07 2001-12-04 酵素
AU2002236595A AU2002236595A1 (en) 2000-12-07 2001-12-04 Enzymes
CA002428390A CA2428390A1 (fr) 2000-12-07 2001-12-04 Enzymes
US10/433,802 US20040063115A1 (en) 2001-12-04 2001-12-04 Enzymes
EP01986129A EP1339834A2 (fr) 2000-12-07 2001-12-04 Enzymes

Applications Claiming Priority (16)

Application Number Priority Date Filing Date Title
US25182400P 2000-12-07 2000-12-07
US60/251,824 2000-12-07
US25431200P 2000-12-08 2000-12-08
US60/254,312 2000-12-08
US25577300P 2000-12-14 2000-12-14
US60/255,773 2000-12-14
US25594000P 2000-12-15 2000-12-15
US25618800P 2000-12-15 2000-12-15
US60/255,940 2000-12-15
US60/256,188 2000-12-15
US25748800P 2000-12-21 2000-12-21
US60/257,488 2000-12-21
US26283901P 2001-01-19 2001-01-19
US60/262,839 2001-01-19
US26440201P 2001-01-26 2001-01-26
US60/264,402 2001-01-26

Publications (2)

Publication Number Publication Date
WO2002046385A2 WO2002046385A2 (fr) 2002-06-13
WO2002046385A3 true WO2002046385A3 (fr) 2003-06-26

Family

ID=27575284

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/047432 WO2002046385A2 (fr) 2000-12-07 2001-12-04 Enzymes

Country Status (5)

Country Link
EP (1) EP1339834A2 (fr)
JP (1) JP2004530415A (fr)
AU (1) AU2002236595A1 (fr)
CA (1) CA2428390A1 (fr)
WO (1) WO2002046385A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020164320A1 (en) * 2000-07-21 2002-11-07 Meyers Rachel A. 56939, a novel human acyl-CoA thioesterase family member and uses thereof
ES2307933T3 (es) 2002-04-26 2008-12-01 Astellas Pharma Inc. Proteina de 35 kda.
ITRM20060037A1 (it) 2006-01-25 2007-07-26 Bio Flag S R L Inibitori della migrazione cellulare mediata dal complesso tra h-prune e gsk-3 relativi usi nella terapia antitumorale

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061748A1 (fr) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 48 proteines humaines secretees
WO2002000840A2 (fr) * 2000-06-23 2002-01-03 Incyte Genomics, Inc. Lyases humaines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061748A1 (fr) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 48 proteines humaines secretees
WO2002000840A2 (fr) * 2000-06-23 2002-01-03 Incyte Genomics, Inc. Lyases humaines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HEWETT-EMMETT D: "Evolution and distribution of the carbonic anhydrase gene families.", EXS. SWITZERLAND 2000, no. 90, 2000, pages 29 - 76, XP002222759 *

Also Published As

Publication number Publication date
JP2004530415A (ja) 2004-10-07
EP1339834A2 (fr) 2003-09-03
WO2002046385A2 (fr) 2002-06-13
CA2428390A1 (fr) 2002-06-13
AU2002236595A1 (en) 2002-06-18

Similar Documents

Publication Publication Date Title
WO2001098468A3 (fr) Proteases
WO2003052075A3 (fr) Enzymes
WO2002008396A3 (fr) Proteases
WO2001051638A3 (fr) Enzymes de metabolisation de medicaments
WO2001090334A3 (fr) Enzymes de metabolisation de medicaments
WO2002004612A3 (fr) Enzymes metabolisant les medicaments
WO2003042357A3 (fr) Enzymes
WO2002038744A3 (fr) Protéases
WO2001096546A3 (fr) Proteine-phosphatases
WO2002026950A3 (fr) Transferases
WO2001098471A3 (fr) Phosphodiesterases
WO2002010363A3 (fr) Proteines phosphatases
WO2001071004A3 (fr) Proteases
WO2002020736A3 (fr) Proteases
WO2001079468A3 (fr) Enzymes metabolisant les medicaments
WO2001059127A3 (fr) Enzymes metabolisant les medicaments
WO2002064795A3 (fr) Enzymes
WO2002024924A3 (fr) Proteine phosphatases
WO2001046443A3 (fr) Proteases
WO2002026998A3 (fr) Hydrolases
WO2002012467A3 (fr) Enzymes métabolisant les médicaments
WO2004003162A3 (fr) Enzymes
WO2001055358A3 (fr) Phosphodiesterases
WO2001083524A3 (fr) Proteines du metabolisme de l'arn
WO2003072729A3 (fr) Enzymes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2428390

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001986129

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2002548103

Country of ref document: JP

Ref document number: 10433802

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001986129

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001986129

Country of ref document: EP